VAGARIGHTS.com launches with biohacking news and reviews – PharmiWeb.com

Posted: June 24, 2021 at 11:48 pm

VAGA Group has launched a new website - VAGARIGHTS.com. The site will be taking over from VAGA.org, which previously published all of the biohacking publication's reviews, articles and news. Vagarights.com will be run by Brian Johnson, who also remains Editor of VAGA.org.

VAGA, the biotechnology company and biohacking publication, has launched a new website: vagarights.com. The site will publish supplement reviews, biohacking articles, and the latest news from the world of biotechnology and biohacking. As was the case with VAGA.org, vagarights.com will primarily focus on specific areas of biohacking, including: neurohacking and nootropics, probiotics and microbiome engineering, immune system modulation, and longevity research. The site will publish in-depth supplement reviews on the latest and most popular nootropics, probiotics, prebiotics, omega 3 capsules, multivitamins, and greens powders on the market.

VAGARIGHTS.com was launched to allow VAGA.org to shift focus onto more popular articles aimed at people new to biohacking, as well as more general interest biotechnology content. VAGARIGHTS.com, by contrast, will amost exclusively focus on supplement reviews and news relating to biotechnology advances.

According to Brian Johnson, Editor and primary author of most of VAGA's content, the new site will help VAGA deliver better content to its readers. He said: "Vagarights.com will allow us to provide much more extensive and in-depth reviews of the newest biohacking supplements while simultaneously giving our readers the kind of readable, fun and engaging content they demand."

VAGARIGHTS is based in New York. You can contact the biotechnology company at 111 Broadway #1006, New York, NY 10006, United States. Alternatively, you can reach the Editor, Brian Johnson, at brian@vagarights.com. Press enquiries should be sent to press@vagarights.com.

View original post here:

VAGARIGHTS.com launches with biohacking news and reviews - PharmiWeb.com

Related Posts